Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Pfizer (NYSE:PFE)

Category: Finance

Pfizer Inc. is set to announce its Q2 financial results, with expected earnings of 46 cents per share and revenue of $13.02 billion. The company received European Commission approval for DURVEQTIX, a gene therapy for hemophilia B. Recent analyst ratings show mixed sentiments, with price targets ranging from $29 to $45.

Keywords: Pfizer, financial results, analyst ratings

Source: Benzinga

Update At: 7/30/2024

Related Sources